Compression Therapy for Neuropathy
Compression therapy may be beneficial for specific types of neuropathy, particularly chemotherapy-induced peripheral neuropathy (CIPN), but is not recommended as a standard treatment for most forms of neuropathy. 1
Evidence for Compression Therapy in Different Types of Neuropathy
Chemotherapy-Induced Peripheral Neuropathy
- Compression therapy shows promise for preventing CIPN during chemotherapy administration:
- One randomized trial using tight surgical gloves during taxane chemotherapy found significantly lower rates of grade ≥2 sensory neuropathies in gloved hands (21%) compared to ungloved hands (76%) 1
- A small trial (38 patients) comparing compression therapy to cryotherapy found similar results with both approaches 1
- A proof-of-concept study combining compression with cryotherapy (cryo-compression at 16°C with cyclic pressure of 5-15 mm Hg) showed preservation of motor nerve function compared to baseline 1
Lymphedema-Related Neuropathy
- For patients with lymphedema who may experience associated neuropathic symptoms:
Other Types of Neuropathy
- No strong evidence supports compression therapy for:
- Diabetic neuropathy
- Entrapment neuropathies (beyond standard medical management)
- Inflammatory neuropathies
Clinical Application of Compression Therapy
When to Consider Compression Therapy
- During administration of neurotoxic chemotherapy (particularly taxanes) to prevent CIPN
- For patients with lymphedema who have associated neuropathic symptoms
- As part of a comprehensive management approach for orthostatic hypotension with neurogenic origin
Practical Implementation
- For chemotherapy-related prevention:
- Apply compression gloves/garments during chemotherapy infusion
- Consider combining with cryotherapy for potentially enhanced effect
- Ensure proper fit to avoid excessive pressure that could worsen symptoms
Limitations and Caveats
- Most evidence is limited to prevention rather than treatment of established neuropathy
- Compression therapy alone is unlikely to provide complete relief for established neuropathy
- Risk of excessive pressure causing further nerve damage if not properly fitted
- Limited evidence for long-term benefits beyond the chemotherapy administration period
Alternative and Complementary Approaches
Pharmacological Options
- Duloxetine is the only medication with strong evidence for treating established CIPN 2
- For other neuropathies, treatment depends on underlying cause:
- Membrane stabilizing agents for ectopic discharges on damaged neural membranes
- Drugs enhancing dorsal horn inhibition for augmenting biogenic amine or GABAergic mechanisms 3
Non-Pharmacological Options
- Exercise may help reduce CIPN symptoms 1
- Physical therapy focusing on neural gliding techniques may benefit compression neuropathies 4
- Acupuncture and scrambler therapy may be considered for CIPN despite limited evidence 2
Conclusion
Compression therapy shows promise primarily for preventing CIPN during chemotherapy administration but has limited evidence supporting its use for established neuropathy of various etiologies. For established neuropathy, evidence-based pharmacological approaches like duloxetine should be considered first-line treatment, with compression therapy potentially serving as an adjunctive approach in specific situations.